News Articles
Latest articles, insights, and updates from the blog.
Need help or want to reach readers?
Have a correction, provider question, or advertising inquiry? Reach the editorial team.
UT Health San Antonio Adds Ketamine to Amputee Care
UT Health San Antonio's Limb Optimization Program now includes ketamine therapy for amputees. Here's what patients should know about this multidisciplinary approach.
Federal Probe Targets Online Ketamine Sellers
Federal officials are investigating online ketamine sellers, WSJ reports. What this regulatory scrutiny means for patients considering at-home ketamine therapy.
COMP360 Phase 3 Data Confirms Rapid TRD Relief
Six-month data from a second Phase 3 trial of COMP360 psilocybin confirms rapid antidepressant effects for treatment-resistant depression. What patients should know.
Why Ketamine Therapy Is Booming Across America
Ketamine use is surging across the U.S. for reasons beyond the drug itself. Here's what patients and families evaluating ketamine therapy need to understand.
Healing With IV Ketamine: Local TV Covers Patient Stories
A Kansas City TV segment highlights IV ketamine therapy's healing potential. Here's what patients and families should consider before starting treatment.
MedShadow Foundation Shares Key Ketamine Depression Facts
MedShadow Foundation releases important facts about ketamine as an antidepressant. Learn what patients should know before considering treatment.
Local TV News Highlights IV Ketamine Treatment Hope
FOX 4 Kansas City covers IV ketamine therapy as a new healing path, signaling growing mainstream acceptance of ketamine treatments.
GH Research Reports Phase 2 Results for Depression Treatment
GH Research reports Phase 2 results for GH001 in postpartum and treatment-resistant depression. Analysis of implications for ketamine patients.
Expert Highlights Key Patient Considerations for Ketamine
Dr. Benjamin Brody highlights critical patient considerations for ketamine therapy at ASCP meeting. Essential guidance for treatment evaluation.
2026 Psychedelic Policy Shifts: What Patients Should Know
A wave of state and federal psychedelic legislation in April 2026 could reshape the therapeutic landscape — here's what ketamine patients need to know.
Ketamine Therapy for Couples: What the Research Shows
Can couples do ketamine therapy together? What 2026 clinical research shows about ketamine for marriage, relationship repair, and joint dosing sessions.
FDA Clears Trial Pairing Ketamine Follow-Up Drug With TMS
The FDA cleared the MIND1 trial testing NRX-101 with robotic TMS for treatment-resistant depression and suicidality. What ketamine patients should know.
CBT After Esketamine Boosts Depression Outcomes in Trial
A new randomized trial finds that adding 16 weeks of CBT after esketamine significantly improves depression and suicidal ideation compared to esketamine alone.